Physician profile
Marjan Aleali
NPI 1770621146
$291.64
in general payments reported to CMS, 2019-2025
9 companies · $18.63 in 2025
The $18.63 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.00 · 2020: $15.61 · 2021: $13.78 · 2022: $53.08 · 2023: $58.33 · 2024: $67.21 · 2025: $18.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $53.13 | 2019 | |
| Braintree Laboratories, INC. | $50.45 | 2020-2025 | Suflave, Sutab |
| Ferring Pharmaceuticals INC. | $41.15 | 2019-2023 | Rebyota |
| Merck Sharp & Dohme LLC | $33.85 | 2022-2023 | Dificid |
| Integra Lifesciences Corporation | $28.79 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Thd America, INC. | $24.73 | 2022 | |
| Convatec INC. | $23.55 | 2023 | |
| Medtronic, INC. | $22.21 | 2024 | Interstim |
| Takeda Pharmaceuticals U.S.A., INC. | $13.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjan Aleali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.